Immulogic Pharmaceutical Corporation
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
As of August 1999, ImmuLogic Pharmaceutical Corporation went out of business. The company operated as a biopharmaceutical company that developed products with a primary emphasis on the diagnosis and treatment of allergies and on the immunological treatment of addiction. In March 1999, the Board of Directors of ImmuLogic approved a plan to liquidate and dissolve the company. The Plan was approved by a majority of the stockholders of ImmuLogic in August 1999. The Plan was the end result of the restructuring, which began in 1997 and included the sale of the company's programs to Xenova plc, the sub-lease of its Waltham, Massachusetts facility, and a reduction in workforce.

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Antibody Intervention in Cocaine Addiction
Cell reactivity to urshiol haptenated peptides